Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7301
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    82.75
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    88,420.76
    -3,009.66 (-3.29%)
     
  • CMC Crypto 200

    1,396.52
    -27.58 (-1.94%)
     
  • GOLD FUTURES

    2,330.80
    -7.60 (-0.33%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,493.00
    -171.50 (-0.97%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,993.78
    -466.30 (-1.21%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Stocks in play: Irwin Naturals Inc

Announces it has entered into a non-binding amended and restated Letter of Intent for a business combination with Braxia Scientific Corp., a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders. The LOI sets forth the material terms and conditions upon which Irwin will acquire all of the issued and outstanding common shares of Braxia. Irwin Naturals Inc shares C.IWIN are trading up $0.20 at $3.95.

Read: